The Journal of Allergy and Clinical Immunology
Volume 108, Issue 3 , Pages 375-381, September 2001

Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity☆☆

  • Csaba Szalai, PhD

      Affiliations

    • Heim Pál Pediatric Hospital Budapest, Hungary
    • the Molecular Immunology Research Group, Hungarian Academy of Sciences Budapest, Hungary
  • ,
  • Gergely T. Kozma, BSc

      Affiliations

    • the Department of Genetics, Cells and Immunobiology, Semmelweis University Budapest Budapest, Hungary
  • ,
  • Adrienne Nagy, MD

      Affiliations

    • Budai Children’s Hospital Budapest, Hungary
  • ,
  • Ágnes Bojszkó, MD

      Affiliations

    • Heim Pál Pediatric Hospital Budapest, Hungary
  • ,
  • Dóra Krikovszky, MD

      Affiliations

    • the 1st Department of Pediatrics, Semmelweis University Budapest. Budapest, Hungary
  • ,
  • Teréz Szabó, MD PhD

      Affiliations

    • Heim Pál Pediatric Hospital Budapest, Hungary
  • ,
  • András Falus, PhD, DSc

      Affiliations

    • the Molecular Immunology Research Group, Hungarian Academy of Sciences Budapest, Hungary
    • the Department of Genetics, Cells and Immunobiology, Semmelweis University Budapest Budapest, Hungary

Received 6 February 2001; received in revised form 29 May 2001; accepted 12 June 2001.

Abstract 

Background: Chemokines play an important role in the pathophysiology of asthma and allergy. Recently, polymorphisms in the gene regulatory region of monocyte chemoattractant protein 1 (MCP-1) and in the promoter region of RANTES have been found; these polymorphisms increase the expression of the chemokines. Objective: We investigated whether the presence of the polymorphisms was associated with atopy or asthma and whether these alleles influenced the severity of asthma in affected individuals. Methods: Three groups of subjects—160 children with asthma (disease severity being classified according to the Global Initiative for Asthma guidelines, modified for children), 151 children with nonasthmatic but allergic phenotype, and 303 children without allergic or asthmatic disorders—were screened with a PCR-based assay for genotyping. Results: The frequency of the –2518G polymorphism in the gene regulatory region of MCP-1 was significantly higher in asthmatic children than in controls (P < .001; odds ratio [OR] = 2.0 [1.4-2.6]) and nonasthmatic atopic children (P < .001; OR = 2.0 [1.4-2.9]). The MCP-1 G/G genotype correlated with asthma severity. In asthmatic children, the MCP-1 –2518G allele was also associated with an increased blood eosinophil level. The promoter polymorphisms in the RANTES gene did not have a detectable effect on the susceptibility to asthma or allergy or on the blood eosinophil count. Conclusion: In this cohort of children, there are associations between carrying G at –2518 of the MCP-1 gene regulatory region and the presence of asthma as well as between asthma severity and homozygosity for the G allele. In asthmatic children, the MCP-1 –2518G polymorphism correlated with increased eosinophil levels. This variant of MCP-1 might belong to the predictor gene set for asthma. (J Allergy Clin Immunol 2001;108:375-81.)

Keywords:  Asthma, atopy, polymorphism, chemokines, MCP-1, RANTES, eosinophils

Abbreviations:  GINA: , Global Initiative for Asthma, HWE: , Hardy-Weinberg equilibrium, MCP-1: , Monocyte chemoattractant protein 1, PEF: , Peak expiratory flow

 

 Supported by OTKA (National Scientific Research Fund) grants T-016111, T032349, and 022287/1997; Hungarian Ministry of Welfare grant ETT 474/96; and a János Bolyai Research Grant.

☆☆ Reprint requests: Csaba Szalai, PhD, Heim Pál Pediatric Hospital, PO Box 66, Budapest H-1958, Hungary.

PII: S0091-6749(01)87618-1

doi:10.1067/mai.2001.117930

The Journal of Allergy and Clinical Immunology
Volume 108, Issue 3 , Pages 375-381, September 2001